Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Interleukin-2-dependent mechanisms of tolerance and immunity in vivo.

Antony PA, Paulos CM, Ahmadzadeh M, Akpinarli A, Palmer DC, Sato N, Kaiser A, Hinrichs CS, Klebanoff CA, Tagaya Y, Restifo NP.

J Immunol. 2006 May 1;176(9):5255-66. Erratum in: J Immunol. 2006 Jun 15;176(12):7788. Heinrichs, Christian [corrected to Hinrichs, Christian S].

2.

Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.

Thornton AM.

Front Biosci. 2006 Jan 1;11:921-7. Review.

PMID:
16146782
3.

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

Antony PA, Restifo NP.

J Immunother. 2005 Mar-Apr;28(2):120-8. Review.

4.

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T.

Immunol Rev. 2001 Aug;182:18-32. Review.

PMID:
11722621
5.

Interleukin-2 signaling and the maintenance of self-tolerance.

Nelson BH.

Curr Dir Autoimmun. 2002;5:92-112. Review.

PMID:
11826762
6.

Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Malek TR, Castro I.

Immunity. 2010 Aug 27;33(2):153-65. doi: 10.1016/j.immuni.2010.08.004. Review.

7.

Tolerance, not immunity, crucially depends on IL-2.

Malek TR, Bayer AL.

Nat Rev Immunol. 2004 Sep;4(9):665-74. Review.

PMID:
15343366
8.

T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.

Cheng G, Yu A, Malek TR.

Immunol Rev. 2011 May;241(1):63-76. doi: 10.1111/j.1600-065X.2011.01004.x. Review.

9.

Balancing autoaggressive and protective T cell responses.

Abbas AK, Lohr J, Knoechel B.

J Autoimmun. 2007 Mar-May;28(2-3):59-61. Epub 2007 Mar 23. Review.

10.

Induction of colitis in IL2-deficient-mice: the role of thymic and peripheral dysregulation in the generation of autoreactive T cells.

Ehrhardt RO, Ludviksson B.

Res Immunol. 1997 Oct-Dec;148(8-9):582-8. Review. No abstract available.

PMID:
9588838
11.

T-cell tolerance in cancer.

Nurieva R, Wang J, Sahoo A.

Immunotherapy. 2013 May;5(5):513-531. doi: 10.2217/imt.13.33. Review.

12.

Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy.

Gao J, Zhao L, Wan YY, Zhu B.

Int J Mol Sci. 2015 May 6;16(5):10267-80. doi: 10.3390/ijms160510267. Review.

13.

IL-2 gene therapy of solid tumors: an approach for the prevention of signal transduction defects in T cells.

Zier KS, Gansbacher B.

J Mol Med (Berl). 1996 Mar;74(3):127-34. Review.

PMID:
8846162
14.
15.

Regulation of tumour immunity by CD25+ T cells.

Gallimore A, Sakaguchi S.

Immunology. 2002 Sep;107(1):5-9. Review. No abstract available.

16.

Leveraging fluorinated glucosamine action to boost antitumor immunity.

Dimitroff CJ.

Curr Opin Immunol. 2013 Apr;25(2):206-13. doi: 10.1016/j.coi.2012.11.003. Epub 2012 Dec 6. Review.

17.

IL-21 Signaling in Immunity.

Leonard WJ, Wan CK.

F1000Res. 2016 Feb 26;5. pii: F1000 Faculty Rev-224. doi: 10.12688/f1000research.7634.1. eCollection 2016. Review.

Supplemental Content

Support Center